🚀 VC round data is live in beta, check it out!
Cereno Scientific Valuation Multiples
Discover revenue and EBITDA valuation multiples for Cereno Scientific and similar public comparables like Searle Co., Starpharma, ProQR Therapeutics, Circio Holding and more.
Cereno Scientific Overview
About Cereno Scientific
Cereno Scientific AB is developing a pipeline of preventive therapeutics to treat cardiovascular and rare diseases by epigenetic modulation through histone deacetylase inhibition (HDACi). The company's program, CS1, is a phase two dual-acting antithrombotic drug aimed at venous thrombosis and stroke prevention for atrial fibrillation. Cereno Scientificalso evaluates the potential of epigenetic modulation for rare diseases related to pulmonary fibrosis, thrombosis, inflammation, and high blood pressure in the pulmonary circulation system.
Founded
2012
HQ
Employees
10
Website
Sectors
Financials (LTM)
EV
$214M
Cereno Scientific Financials
Cereno Scientific reported last 12-month revenue of — and negative EBITDA of ($10M).
In the same LTM period, Cereno Scientific generated ($10M) in EBITDA losses and had net loss of ($13M).
Revenue (LTM)
Cereno Scientific P&L
In the most recent fiscal year, Cereno Scientific reported revenue of — and EBITDA of ($8M).
Cereno Scientific expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Gross Profit | — | XXX | $5M | XXX | XXX | XXX |
| EBITDA | ($10M) | XXX | ($8M) | XXX | XXX | XXX |
| Net Profit | ($13M) | XXX | ($13M) | XXX | XXX | XXX |
| Net Debt | — | — | $5M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Cereno Scientific Stock Performance
Cereno Scientific has current market cap of $209M, and enterprise value of $214M.
Market Cap Evolution
Cereno Scientific's stock price is $0.67.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $214M | $209M | -0.1% | XXX | XXX | XXX | $-0.04 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCereno Scientific Valuation Multiples
Cereno Scientific trades at (22.1x) EV/EBITDA.
Cereno Scientific Financial Valuation Multiples
As of April 18, 2026, Cereno Scientific has market cap of $209M and EV of $214M.
Equity research analysts estimate Cereno Scientific's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Cereno Scientific has a P/E ratio of (15.6x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $209M | XXX | $209M | XXX | XXX | XXX |
| EV (current) | $214M | XXX | $214M | XXX | XXX | XXX |
| EV/EBITDA | (22.1x) | XXX | (27.2x) | XXX | XXX | XXX |
| EV/EBIT | (22.0x) | XXX | (26.4x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 44.4x | XXX | XXX | XXX |
| P/E | (15.6x) | XXX | (16.3x) | XXX | XXX | XXX |
| EV/FCF | (14.6x) | XXX | (14.7x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Cereno Scientific Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Cereno Scientific Margins & Growth Rates
Cereno Scientific's revenue in the last fiscal year grew by —.
Cereno Scientific's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $1.3M for the same period.
Cereno Scientific Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA Growth | 47% | XXX | 67% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $1.3M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Cereno Scientific Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Cereno Scientific | XXX | XXX | XXX | XXX | XXX | XXX |
| Searle Co. | XXX | XXX | XXX | XXX | XXX | XXX |
| Starpharma | XXX | XXX | XXX | XXX | XXX | XXX |
| ProQR Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Circio Holding | XXX | XXX | XXX | XXX | XXX | XXX |
| Sagimet Biosciences | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Cereno Scientific M&A Activity
Cereno Scientific acquired XXX companies to date.
Last acquisition by Cereno Scientific was on XXXXXXXX, XXXXX. Cereno Scientific acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Cereno Scientific
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCereno Scientific Investment Activity
Cereno Scientific invested in XXX companies to date.
Cereno Scientific made its latest investment on XXXXXXXX, XXXXX. Cereno Scientific invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Cereno Scientific
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Cereno Scientific
| When was Cereno Scientific founded? | Cereno Scientific was founded in 2012. |
| Where is Cereno Scientific headquartered? | Cereno Scientific is headquartered in Sweden. |
| How many employees does Cereno Scientific have? | As of today, Cereno Scientific has over 10 employees. |
| Who is the CEO of Cereno Scientific? | Cereno Scientific's CEO is Sten Sorensen. |
| Is Cereno Scientific publicly listed? | Yes, Cereno Scientific is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Cereno Scientific? | Cereno Scientific trades under CRNO B ticker. |
| When did Cereno Scientific go public? | Cereno Scientific went public in 2016. |
| Who are competitors of Cereno Scientific? | Cereno Scientific main competitors are Searle Co., Starpharma, ProQR Therapeutics, Circio Holding. |
| What is the current market cap of Cereno Scientific? | Cereno Scientific's current market cap is $209M. |
| Is Cereno Scientific profitable? | No, Cereno Scientific is not profitable. |
| What is the current EBITDA of Cereno Scientific? | Cereno Scientific has negative EBITDA and is not profitable. |
| What is the current EV/EBITDA multiple of Cereno Scientific? | Current EBITDA multiple of Cereno Scientific is (22.1x). |
| What is the current FCF of Cereno Scientific? | Cereno Scientific's last 12 months FCF is ($15M). |
| What is the current EV/FCF multiple of Cereno Scientific? | Current FCF multiple of Cereno Scientific is (14.6x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.